Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the Central Nervous System without pathogenesis

Citation
Ca. Jackson et al., Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the Central Nervous System without pathogenesis, HUM GENE TH, 12(15), 2001, pp. 1827-1841
Citations number
53
Categorie Soggetti
Molecular Biology & Genetics
Journal title
HUMAN GENE THERAPY
ISSN journal
10430342 → ACNP
Volume
12
Issue
15
Year of publication
2001
Pages
1827 - 1841
Database
ISI
SICI code
1043-0342(20011015)12:15<1827:RIIOPR>2.0.ZU;2-L
Abstract
Poliovirus-based vectors (replicons) can be used for gene delivery to motor neurons of the CNS. In the current study, a replicon encoding green fluore scent protein (GFP) was encapsidated into authentic poliovirions, using est ablished procedures. Intrathecal delivery of encapsidated replicons encodin g GFP to the CNS of mice transgenic for the human poliovirus receptor did n ot result in any functional deficits as judged by behavioral testing. Histo logical analysis of the CNS of mice given a single intrathecal injection of poliovirus replicons encoding GFP revealed no obvious pathogenesis in neur ons (or other cell types) within the CNS. The expression of GFP was confine d to motor neurons throughout the neuroaxis; a time course of expression of GFP revealed that expression was detectable 24 hr postinoculation and retu rned to background levels by 120 hr postinoculation. A procedure was devise d to allow repetitive inoculation of replicons within the same animal. Beha vioral testing of animals that had received 6 to 13 independent inoculation s of replicons revealed no functional deficits. Histological analysis of th e CNS from animals that had received 6 to 13 sequential inoculations of rep licons revealed no obvious abnormalities in neurons or other cell types in the CNS; expression of GFP was demonstrated in neurons 24 to 72 hr after th e final inoculation of the replicon. Furthermore, there was no obvious infl ammatory response in the CNS after the multiple inoculations. These studies establish the safety and efficacy of replicons for gene delivery to the CN S and are discussed with respect to use of replicons as new therapeutic str ategies for spinal cord injuries and/or neurological diseases.